MDS to Present at Thomas Weisel Partners Healthcare Conference

    TORONTO, Aug. 31 /CNW/ - MDS Inc. (TSX: MDS; NYSE:   MDZ), a leading
provider of products and services to the global life sciences markets,
announced today that Stephen P. DeFalco, President and Chief Executive
Officer, will be presenting at the Thomas Weisel Partners Healthcare
Conference in Boston on Friday, September 7th, at 9:45 am Eastern Standard
    Interested parties may access the live webcast by visiting the "Latest
News" section of the MDS home page at and clicking on the
conference link. An audio archive and the presentation slides will also be
available after the event on the "Webcasts & Presentations" page in our "For
Investors" section of the MDS website.

    MDS Inc. is a global life sciences company that provides market-leading
products and services that our customers need for the development of drugs and
the diagnosis and treatment of disease. We are a leading global provider of
pharmaceutical contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than 6,200 highly
skilled people in 28 countries. Find out more at or by calling
1-888-MDS-7222, 24 hours a day.

For further information:

For further information: Investors: Sharon Mathers, Senior
Vice-President, Investor Relations and External Communications, (416) 675-6777
ext. 34721,

Organization Profile

Nordion Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890